Literature DB >> 28964805

Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.

Seong Joon Ahn1, Jooyoung Joung1, Han Woong Lim1, Byung Ro Lee2.   

Abstract

PURPOSE: To investigate the distribution of outer retinal changes in hydroxychloroquine (HCQ) retinopathy and explore optical coherence tomography (OCT) protocols to maximize the sensitivity of HCQ retinopathy detection in Asian patients.
DESIGN: Diagnostic validity assessment.
METHODS: Setting: Institutional. PATIENT POPULATION: Forty-eight eyes (24 patients) with HCQ retinopathy underwent 6-mm horizontal and vertical line scans and 6 × 6-mm2 volume scans using spectral-domain OCT (SD-OCT), and 9-mm line scans and 6 × 6-mm2 and 12 × 9-mm2 volume scans using swept-source OCT (SS-OCT). OBSERVATION PROCEDURES: Distances from the fovea to the defective photoreceptors were measured in the temporal, nasal, superior, and inferior directions from line scan OCT images. The sensitivity of retinopathy detection, indicated by photoreceptor defects, was compared among protocols. MAIN OUTCOME MEASURES: Detection of photoreceptor defects and distances from the fovea to the defects.
RESULTS: The average minimum distance from the fovea to an area of photoreceptor defects was 1.84 ± 1.26 mm (mean ± standard deviation). The distances were greater than 3 mm horizontally and vertically in 15 (31.3%) and 17 (35.4%) eyes with HCQ retinopathy, respectively, and only wide-field line or volume scans could detect defects in the eyes. The 9-mm line scans detected HCQ retinopathy significantly better than 6-mm scans (P < .001); the sensitivity of the wide volume scan was significantly greater than the standard volume scan (P = .001). The 12 × 9-mm2 volume scan detected retinopathy with the greatest sensitivity (100%).
CONCLUSIONS: Our study recommends a wide-field OCT scan to screen Asian patients taking HCQ medications.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28964805     DOI: 10.1016/j.ajo.2017.09.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

Review 1.  [Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

Authors:  A Rickmann; S Al-Nawaiseh; L Ramirez; S Röhrig; M Ladewig; P Szurman; G Szurman
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

2.  Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.

Authors:  Obinna Ugwuegbu; Atsuro Uchida; Rishi P Singh; Lucas Beven; Ming Hu; Stephanie Kaiser; Sunil K Srivastava; Justis P Ehlers
Journal:  Br J Ophthalmol       Date:  2018-09-06       Impact factor: 4.638

3.  Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.

Authors:  Mehmet Bulut; Melih Akıdan; Onursal Gözkaya; Muhammet Kazım Erol; Ayşe Cengiz; Hasan Fatih Çay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-29       Impact factor: 3.117

4.  Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy.

Authors:  Ko Eun Kim; Ji Hong Kim; Young Hwan Kim; Seong Joon Ahn
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

5.  Visual field examinations using different strategies in Asian patients taking hydroxychloroquine.

Authors:  Ko Eun Kim; So Jung Ryu; Young Hwan Kim; Yuchan Seo; Seong Joon Ahn
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

6.  Deep Learning-Based Automatic Detection of Ellipsoid Zone Loss in Spectral-Domain OCT for Hydroxychloroquine Retinal Toxicity Screening.

Authors:  Tharindu De Silva; Gopal Jayakar; Peyton Grisso; Nathan Hotaling; Emily Y Chew; Catherine A Cukras
Journal:  Ophthalmol Sci       Date:  2021-09-25

Review 7.  Spatial and spatio-temporal statistical analyses of retinal images: a review of methods and applications.

Authors:  Wenyue Zhu; Ruwanthi Kolamunnage-Dona; Yalin Zheng; Simon Harding; Gabriela Czanner
Journal:  BMJ Open Ophthalmol       Date:  2020-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.